Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Investors Of Pacific Biosciences Of California Inc Can Join Fraud Investigation With The Schall Law Firm
11:00pm, Wednesday, 07'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscien
Compared to Estimates, Pacific Biosciences (PACB) Q2 Earnings: A Look at Key Metrics
08:36pm, Wednesday, 07'th Aug 2024
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metric
Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates
08:16pm, Wednesday, 07'th Aug 2024
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago.
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
11:25am, Wednesday, 07'th Aug 2024
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Pacific Biosciences Of California Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm
03:45pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bioscien
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Singapore's National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia
04:05pm, Monday, 05'th Aug 2024
This joint effort will harness PacBio's state-of-the-art HiFi sequencing technology to offer profound insights into genetic diversity, disease mechanisms, and clinical diagnoses within Singapore's mul
Pacific Biosciences of California, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - PACB
07:30am, Monday, 05'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm
10:27pm, Friday, 02'nd Aug 2024
LOS ANGELES--(BUSINESS WIRE)--PACB Investors Have Opportunity to Join Pacific Biosciences of California, Inc. Fraud Investigation with the Schall Law Firm.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Pacific Biosciences of California, Inc. (PACB)
12:45pm, Thursday, 01'st Aug 2024
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Pacific Biosciences of California, Inc. ("Pacific Biosciences of California,
Pacific Biosciences of California (PACB) Flat As Market Sinks: What You Should Know
07:20pm, Tuesday, 30'th Jul 2024
The latest trading day saw Pacific Biosciences of California (PACB) settling at $2.05, representing no change from its previous close.
Pacific Biosciences of California (PACB) Ascends While Market Falls: Some Facts to Note
07:20pm, Wednesday, 24'th Jul 2024
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.88, signifying a +1.62% move from its prior day's close.
PacBio's (PACB) Revio System to Boost Novogene's German Lab
11:01am, Wednesday, 24'th Jul 2024
PacBio (PACB) announces that Novogene is set to use PACB's Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany.
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
09:05am, Tuesday, 23'rd Jul 2024
Highly accurate long-read sequencing data will be used at Novogene's new lab in Munich, supporting customers across a network of leading research institutions Highly accurate long-read sequencing data
